 | • レポートコード：MRC2-11QY11212 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバーキットリンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（高度ドレッシング、生物製剤、従来型熱傷治療製品、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バーキットリンパ腫治療薬の競争状況、市場シェア ・世界のバーキットリンパ腫治療薬市場：種類別市場規模 2015年-2020年（高度ドレッシング、生物製剤、従来型熱傷治療製品、その他） ・世界のバーキットリンパ腫治療薬市場：種類別市場規模予測 2021年-2026年（高度ドレッシング、生物製剤、従来型熱傷治療製品、その他） ・世界のバーキットリンパ腫治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界のバーキットリンパ腫治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米のバーキットリンパ腫治療薬市場分析：米国、カナダ ・ヨーロッパのバーキットリンパ腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバーキットリンパ腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバーキットリンパ腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバーキットリンパ腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda、Avita Medical、Smith＆Nephew、Coloplast Group、Systagenix Wound Management、MölnlyckeHealthCare、ConvaTec、Osiris Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreover, the number of non-fatal burn incidences is very high and require serious medical attention.
For small burns, the wound closure with autologous skin can be performed but for burns greater than 50 percent total body surface area, wound closure must be achieved by using combination of autograft and allograft or synthetic wound coverings. In case of large burns, cadaver skin have been proved to be life saving. Synthetic covers which can be used as alternatives of cadaver skin include, Biobrane (Smith & Nephew plc), Dermagraft-TC (MediLexicon International Ltd.). The global burn treatment market is driven from traditional products in categories such as anti-infective drugs and pressure-relief devices. However, the advanced therapies which reduce healing time and achieve significant cost savings will drive the future burn treatment market. Since the burn trauma continues to have a large socioeconomic impact on the healthcare, the market for burn treatment will expand as more people get access to advanced trauma care.
Market Analysis and Insights: Global Burkitt Lymphoma Therapeutics Market
The global Burkitt Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Burkitt Lymphoma Therapeutics Scope and Market Size
Burkitt Lymphoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Burkitt Lymphoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda
Avita Medical
Smith＆Nephew
Coloplast Group
Systagenix Wound Management
MölnlyckeHealthCare
ConvaTec
Osiris Therapeutics
Market segment by Type, the product can be split into
Advanced Dressing
Biologics
Traditional Burn Care Products
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Burkitt Lymphoma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Burkitt Lymphoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Advanced Dressing
1.4.3 Biologics
1.4.4 Traditional Burn Care Products
1.4.5 Others
1.5 Market by Application
1.5.1 Global Burkitt Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Burkitt Lymphoma Therapeutics Market Perspective (2015-2026)
2.2 Global Burkitt Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Burkitt Lymphoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Burkitt Lymphoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Burkitt Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Burkitt Lymphoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Burkitt Lymphoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Burkitt Lymphoma Therapeutics Players by Market Size
3.1.1 Global Top Burkitt Lymphoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Burkitt Lymphoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Burkitt Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Burkitt Lymphoma Therapeutics Market Concentration Ratio
3.2.1 Global Burkitt Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Burkitt Lymphoma Therapeutics Revenue in 2019
3.3 Burkitt Lymphoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Burkitt Lymphoma Therapeutics Product Solution and Service
3.5 Date of Enter into Burkitt Lymphoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Burkitt Lymphoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Burkitt Lymphoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Burkitt Lymphoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Burkitt Lymphoma Therapeutics Market Size (2015-2020)
6.2 Burkitt Lymphoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Burkitt Lymphoma Therapeutics Market Size (2015-2020)
7.2 Burkitt Lymphoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Burkitt Lymphoma Therapeutics Market Size (2015-2020)
8.2 Burkitt Lymphoma Therapeutics Key Players in China (2019-2020)
8.3 China Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
8.4 China Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Burkitt Lymphoma Therapeutics Market Size (2015-2020)
9.2 Burkitt Lymphoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Burkitt Lymphoma Therapeutics Market Size (2015-2020)
10.2 Burkitt Lymphoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Burkitt Lymphoma Therapeutics Market Size (2015-2020)
11.2 Burkitt Lymphoma Therapeutics Key Players in India (2019-2020)
11.3 India Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
11.4 India Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Burkitt Lymphoma Therapeutics Market Size (2015-2020)
12.2 Burkitt Lymphoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Burkitt Lymphoma Therapeutics Introduction
13.1.4 Takeda Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Avita Medical
13.2.1 Avita Medical Company Details
13.2.2 Avita Medical Business Overview
13.2.3 Avita Medical Burkitt Lymphoma Therapeutics Introduction
13.2.4 Avita Medical Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.2.5 Avita Medical Recent Development
13.3 Smith＆Nephew
13.3.1 Smith＆Nephew Company Details
13.3.2 Smith＆Nephew Business Overview
13.3.3 Smith＆Nephew Burkitt Lymphoma Therapeutics Introduction
13.3.4 Smith＆Nephew Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.3.5 Smith＆Nephew Recent Development
13.4 Coloplast Group
13.4.1 Coloplast Group Company Details
13.4.2 Coloplast Group Business Overview
13.4.3 Coloplast Group Burkitt Lymphoma Therapeutics Introduction
13.4.4 Coloplast Group Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.4.5 Coloplast Group Recent Development
13.5 Systagenix Wound Management
13.5.1 Systagenix Wound Management Company Details
13.5.2 Systagenix Wound Management Business Overview
13.5.3 Systagenix Wound Management Burkitt Lymphoma Therapeutics Introduction
13.5.4 Systagenix Wound Management Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.5.5 Systagenix Wound Management Recent Development
13.6 MölnlyckeHealthCare
13.6.1 MölnlyckeHealthCare Company Details
13.6.2 MölnlyckeHealthCare Business Overview
13.6.3 MölnlyckeHealthCare Burkitt Lymphoma Therapeutics Introduction
13.6.4 MölnlyckeHealthCare Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.6.5 MölnlyckeHealthCare Recent Development
13.7 ConvaTec
13.7.1 ConvaTec Company Details
13.7.2 ConvaTec Business Overview
13.7.3 ConvaTec Burkitt Lymphoma Therapeutics Introduction
13.7.4 ConvaTec Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.7.5 ConvaTec Recent Development
13.8 Osiris Therapeutics
13.8.1 Osiris Therapeutics Company Details
13.8.2 Osiris Therapeutics Business Overview
13.8.3 Osiris Therapeutics Burkitt Lymphoma Therapeutics Introduction
13.8.4 Osiris Therapeutics Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020)
13.8.5 Osiris Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Burkitt Lymphoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Burkitt Lymphoma Therapeutics Revenue
Table 3. Ranking of Global Top Burkitt Lymphoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Burkitt Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Advanced Dressing
Table 6. Key Players of Biologics
Table 7. Key Players of Traditional Burn Care Products
Table 8. Key Players of Others
Table 9. Global Burkitt Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Burkitt Lymphoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Burkitt Lymphoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Burkitt Lymphoma Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Burkitt Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Burkitt Lymphoma Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Burkitt Lymphoma Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Burkitt Lymphoma Therapeutics Players
Table 20. Global Burkitt Lymphoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Burkitt Lymphoma Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Burkitt Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Burkitt Lymphoma Therapeutics as of 2019)
Table 23. Global Burkitt Lymphoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Burkitt Lymphoma Therapeutics Product Solution and Service
Table 26. Date of Enter into Burkitt Lymphoma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Burkitt Lymphoma Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Burkitt Lymphoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Burkitt Lymphoma Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Burkitt Lymphoma Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 36. North America Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 38. North America Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 42. Europe Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 48. China Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 50. China Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 54. Japan Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 66. India Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 68. India Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Burkitt Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Burkitt Lymphoma Therapeutics Market Share (2019-2020)
Table 72. Central & South America Burkitt Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Burkitt Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Burkitt Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Burkitt Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Product
Table 79. Takeda Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 80. Takeda Recent Development
Table 81. Avita Medical Company Details
Table 82. Avita Medical Business Overview
Table 83. Avita Medical Product
Table 84. Avita Medical Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 85. Avita Medical Recent Development
Table 86. Smith＆Nephew Company Details
Table 87. Smith＆Nephew Business Overview
Table 88. Smith＆Nephew Product
Table 89. Smith＆Nephew Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 90. Smith＆Nephew Recent Development
Table 91. Coloplast Group Company Details
Table 92. Coloplast Group Business Overview
Table 93. Coloplast Group Product
Table 94. Coloplast Group Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 95. Coloplast Group Recent Development
Table 96. Systagenix Wound Management Company Details
Table 97. Systagenix Wound Management Business Overview
Table 98. Systagenix Wound Management Product
Table 99. Systagenix Wound Management Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 100. Systagenix Wound Management Recent Development
Table 101. MölnlyckeHealthCare Company Details
Table 102. MölnlyckeHealthCare Business Overview
Table 103. MölnlyckeHealthCare Product
Table 104. MölnlyckeHealthCare Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 105. MölnlyckeHealthCare Recent Development
Table 106. ConvaTec Company Details
Table 107. ConvaTec Business Overview
Table 108. ConvaTec Product
Table 109. ConvaTec Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 110. ConvaTec Recent Development
Table 111. Osiris Therapeutics Business Overview
Table 112. Osiris Therapeutics Product
Table 113. Osiris Therapeutics Company Details
Table 114. Osiris Therapeutics Revenue in Burkitt Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 115. Osiris Therapeutics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Burkitt Lymphoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Advanced Dressing Features
Figure 3. Biologics Features
Figure 4. Traditional Burn Care Products Features
Figure 5. Others Features
Figure 6. Global Burkitt Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Burkitt Lymphoma Therapeutics Report Years Considered
Figure 11. Global Burkitt Lymphoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Burkitt Lymphoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Burkitt Lymphoma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Burkitt Lymphoma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Burkitt Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Burkitt Lymphoma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Burkitt Lymphoma Therapeutics Revenue in 2019
Figure 18. North America Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Burkitt Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
バーキットリンパ腫治療の世界市場（～2026年） Market Analysis and Insights: Global Burkitt Lymphoma Treatment Market The global Burkitt Lymphoma Treatment market size is projected to reach US$ 727 million by 2026, from US$ 708.4 million in 2020, at a CAGR of 2.4%% during 2021-2026. Global Burkitt Lymphoma Treatment Scope and Market Size Burkitt…- ホジキンリンパ腫治療薬の世界市場（～2026年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 未分化大細胞リンパ腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Anaplastic Large Cell Lymphoma Therapeutics Market The global Anaplastic Large Cell Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anaplastic Large Cell Lymph…
- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…